Neoplasms, Unknown Primary
"Neoplasms, Unknown Primary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metastases in which the tissue of origin is unknown.
| Descriptor ID |
D009382
|
| MeSH Number(s) |
C04.697.650.895 C23.550.727.650.895
|
| Concept/Terms |
Neoplasms, Unknown Primary- Neoplasms, Unknown Primary
- Occult Primary Neoplasms
- Neoplasms, Occult Primary
- Neoplasm, Occult Primary
- Occult Primary Neoplasm
- Primary Neoplasm, Occult
- Primary Neoplasms, Occult
- Unknown Primary Neoplasms
- Neoplasm, Unknown Primary
- Primary Neoplasm, Unknown
- Primary Neoplasms, Unknown
- Unknown Primary Neoplasm
Unknown Primary Tumors- Unknown Primary Tumors
- Primary Tumor, Unknown
- Primary Tumors, Unknown
- Tumor, Unknown Primary
- Tumors, Unknown Primary
- Unknown Primary Tumor
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Unknown Primary".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Unknown Primary".
This graph shows the total number of publications written about "Neoplasms, Unknown Primary" by people in this website by year, and whether "Neoplasms, Unknown Primary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 8 | 1 | 9 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasms, Unknown Primary" by people in Profiles.
-
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic. Eur J Cancer. 2020 08; 135:147-149.
-
Familial cancer of unknown primary. Int J Clin Oncol. 2019 Oct; 24(10):1328-1331.
-
Paraneoplastic syndromes in cancers of unknown primary: An unknown field for oncologists. Bull Cancer. 2019 Jun; 106(6):590-603.
-
Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism. Thromb Res. 2018 11; 171:92-96.
-
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thromb Res. 2018 11; 171:97-102.
-
Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism. PLoS One. 2018; 13(3):e0194673.
-
CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor. Dtsch Arztebl Int. 2018 03 09; 115(10):157-162.
-
Radioguided Occult Lesion Localization: Technical Procedures and Clinical Applications. Clin Nucl Med. 2017 Dec; 42(12):e498-e503.
-
Where Did It Start? Subcutaneous Metastatic Melanoma. Am J Med. 2018 Jan; 131(1):41-44.
-
CT Image-based Decision Support System for Categorization of Liver Metastases Into Primary Cancer Sites: Initial Results. Acad Radiol. 2017 12; 24(12):1501-1509.